Storia in 3 fonti

Manipal Health IPO: Leading operator at premium valuation

Explore Manipal Health's IPO details, growth potential, and investment recommendations amid premium valuations and acquisition-driven expansion.

Raccontata da

theprint.in

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.com3 g fa

Can Manipal Health IPO deliver long-term growth for high risk investors?

Manipal Health plans ₹8,000-crore IPO; occupancy declined to 64.5% in FY26 despite 25% YoY revenue growth. Ebitda margin fell 190bp and P/E of 85 exceeds peers by 22%—clear signals of operational pressure that warrant caution on aggressive valuation.

Leggi questa versione → originale

thehindubusinessline.com3 g fa

Manipal Health collects ₹4,167 crore from anchor investors; IPO opens for public subscription

Manipal Health raised ₹4,167 crore from anchor investors in a ₹9,275-crore IPO valuing the 49-hospital network at ₹77,600 crore. Tier-1 anchor backing signals India's healthcare consolidation and opens IT budget for AI diagnostics and health-tech platforms.

Manipal Health IPO: Leading operator at premium valuation

Confronto fonti

Can Manipal Health IPO deliver long-term growth for high risk investors?

Manipal Health collects ₹4,167 crore from anchor investors; IPO opens for public subscription

Timeline cronologica

Manipal Health Enterprises collects Rs 4,167-cr from anchor investors ahead of IPO

Manipal Health IPO opens today: Price band, subscription details and brokerage recommendations

Manipal Health Enterprises collects Rs 4,167-cr from anchor investors ahead of IPO

Manipal Health IPO opens today; GMP at just 2%: Should you subscribe?

Manipal Health collects ₹4,167 crore from anchor investors; IPO opens for public subscription

Manipal Health IPO: Leading operator at premium valuation

Can Manipal Health IPO deliver long-term growth for high risk investors?

Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?

Manipal Health IPO Day 3 Update: GMP remains at 1%, subscription at 45%. Should you Subscribe or Skip?

Manipal Health Enterprises IPO subscribed 2.54X so far on closing day